NCBIO advocates for North Carolina’s life sciences industry at the state and national levels. In North Carolina, the Organization represents its members at the North Carolina General Assembly and before state courts, regulatory agencies and executive branch policy leaders.
At the national level, NCBIO works with the national Biotechnology Innovation Organization (BIO), the Pharmaceutical Research & Manufacturers of America (PhRMA), AdvaMed and the Medical Device Manufacturers Association (MDMA) to support appropriate federal policies and to keep members of North Carolina's congressional delegation informed as to industry needs and priorities.
The 2017 NCBIO Legislative Agenda approved by the Board of Directors at the February meeting focuses on three key areas:
Click for more details on the agenda.